SynDevRx
PrivateLast Round
Series C
Dec 22, 2025
Total Funding Raised
$31.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SynDevRx is a clinical-stage biotechnology company that develops treatments for cancers sensitive to metabolic hormones.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynDevRx Comparables
Compare SynDevRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cureteq AG | 80% | |
| Kalohexis | 79% | |
| Actimed Therapeutics | 78% | |
SynDevRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 22, 2025 | ||||
| Grant | Jan 9, 2025 | ||||
| VC Round | Nov 4, 2024 | ||||
| Grant | Aug 31, 2022 | ||||
| Series B | Jan 25, 2022 | ||||
Series B | Jan 9, 2020 |
Key People
Founding team and executive leadership
SynDevRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 190% MoM.
- Dec 22, 2025
Raised $6.4M in Series C funding.
SynDevRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynDevRx's valuation, stock price, and market status.